Neuronetics, INC Form 4 insider transactions

Neuronetics, Inc. Executive Vice President, Chief Legal Officer, and Corporate Secretary William Andrew Macan received a grant of 210,000 restricted stock units.

Neuronetics' Executive Vice President, Chief Legal Officer, and Corporate Secretary, William Andrew Macan, sold 3,485 shares of common stock to cover tax withholding obligations related to a restricted stock unit vesting.

Neuronetics, Inc. President and CEO, Keith J. Sullivan, sold 40,976 shares of common stock to cover tax withholding obligations related to a restricted stock unit award.

Neuronetics, Inc.'s EVP, General Counsel, Chief Compliance Officer, and Corporate Secretary, William Andrew Macan, was granted 164,361 restricted stock units.

Neuronetics, Inc.'s EVP, CFO, and Treasurer, Steven Pfanstiel, was granted 170,212 restricted stock units, increasing his beneficial ownership to 570,212 shares.

Neuronetics Director Robert Cascella acquired 10,531 shares of common stock on October 20, 2025, as part of his non-employee director compensation plan, increasing his direct beneficial ownership to 588,767 shares.

Neuronetics Director Sheryl L Conley acquired 7,326 shares of common stock as part of her non-employee director compensation plan, increasing her total beneficial ownership to 221,716 shares.

Neuronetics Director Glenn P. Muir acquired 7,554 shares of common stock on October 20, 2025, as part of his non-employee director compensation plan.

Neuronetics Director Sasha Cucuz acquired 6,410 shares of common stock in lieu of a cash retainer, increasing beneficial ownership.

Madryn Asset Management, a 10% owner and director of Neuronetics, Inc., reported the sale of 3.5 million shares of common stock for approximately $13 million, executed under a pre-planned trading arrangement.

Steven Pfanstiel, EVP, CFO, and Treasurer of Neuronetics, Inc., was granted 400,000 restricted stock units (RSUs) on July 15, 2025, as part of an equity compensation plan.

Neuronetics, Inc. Director Sasha Cucuz has reported the acquisition of 30,000 restricted stock units (RSUs) on May 22, 2025, as part of a compensation award.

Neuronetics, Inc. Director Glenn Muir has been granted 30,000 restricted stock units, increasing his beneficial ownership to 364,262 shares.

Neuronetics, Inc. Director Megan Rosengarten has been granted 30,000 Restricted Stock Units (RSUs), increasing her total beneficial ownership to 140,890 shares.

Neuronetics, Inc. Director Robert Cascella was granted 36,250 restricted stock units, increasing his beneficial ownership to 578,236 shares.

Neuronetics, Inc. Director Avinash Amin has been granted 30,000 restricted stock units (RSUs), increasing his beneficial ownership to 42,500 shares.

Neuronetics, Inc. Director Sheryl L. Conley has been granted 30,000 restricted stock units (RSUs) as part of her compensation, aligning her interests with long-term shareholder value.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., sold a total of 200,000 shares of common stock in two transactions on May 12 and May 13, 2025.

Keith Sullivan, CEO of Neuronetics, files an amended SEC Form 4 to correct the vesting dates and threshold achievement percentage of a performance restricted stock unit award.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., files an amendment to a previous Form 4 to correct the vesting dates and threshold achievement percentage of a performance restricted stock unit award.

William Andrew Macan, an executive at Neuronetics, filed an amendment to a previous SEC Form 4 to correct the vesting dates and threshold achievement percentage of a performance restricted stock unit award.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., sold 1,867 shares of common stock on March 4, 2025, to satisfy tax withholding obligations.

William Andrew Macan, EVP, GC, CCO and CS of Neuronetics, Inc., sold 377 shares of common stock to cover tax obligations arising from the vesting of restricted stock units.

Keith J. Sullivan, President and CEO of Neuronetics, Inc., reports acquisition of common stock and performance-based restricted stock units.

William Andrew Macan, EVP, GC, CCO and CS of Neuronetics, Inc., was granted restricted stock units and performance-based restricted stock units on February 24, 2025.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., reports the acquisition of 157,500 shares of common stock and 78,750 performance restricted stock units (PRSUs) on February 24, 2025.

Neuronetics CEO Keith J. Sullivan sold shares of common stock on February 18th and 19th, 2025, to satisfy tax withholding obligations related to the vesting of restricted stock units.

William Andrew Macan, an executive at Neuronetics, sold shares to cover tax obligations related to vesting of restricted stock units.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., sold 17,307 shares of common stock on February 14, 2025, to cover tax withholding obligations.

Stephen Furlong, EVP, CFO and Treasurer of Neuronetics, Inc., sold 10,845 shares of common stock on February 12, 2025, to satisfy tax withholding obligations upon vesting of a restricted stock unit award.